Europe Lab-on-a-Chip and Microarrays Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Europe Lab-on-a-Chip and Microarrays (Biochip) Companies and the market is segmented By Type (Lab-on-a-Chip, Microarray), By Products, By Application, By End User and Country.

Europe Lab-on-a-Chip and Microarrays (Biochip) Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
Market Snapshot
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 11.13 %

Major Players

Europe Lab-on-a-chip and Microarrays (Biochip) Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Europe Lab-on-a-Chip and Microarrays (Biochip) Market Analysis

Europe Lab-on-a-Chip and Microarrays (Biochip) Market are expected to witness a high CAGR growth during the forecast period, owing to the rising burden of chronic diseases, increasing applications of proteomics and genomics, and increasing demand for point of care testing. According to the Cancer Atlas, in 2018, approximately 3.9 million new cases of cancer and almost 1.9 million deaths were registered in Europe. Protein microarrays are one of the advancing tools which hold a promising future in cancer proteomics research. Therefore, these factors are expected to fuel market growth in the forecast period.

Europe Lab-on-a-Chip and Microarrays (Biochip) Market Trends

This section covers the major market trends shaping the Europe Biochip Market according to our research experts:

Microarrays are Expected to Exhibit a Significant Growth During the Forecast Period.

Microarrays are expected to show significant growth in the market during the forecast period, owing to the growing burden of morbidity and mortality due to chronic diseases and novel technologies developing in the market. 

According to the European Cardiovascular Disease Statistics, 2017, around 45% of all the death is caused due to cardiovascular diseases and almost 37% of deaths in the European Union are due to cardiovascular diseases. Microarrays are capable of profiling lncRNA and mRNA expression in atherosclerotic plaques. 

Furthermore, in 2019, Quotient Limited received an approval (CE Mark) for Immunohematology (IH) Microarray for use with its MosaiQ diagnostic platform. Therefore, the aforementioned factors are expected to boost the demand for microarrays in the market over the forecast period.

Europe Biochip market Trend.png

Europe Lab-on-a-Chip and Microarrays (Biochip) Industry Overview

Some of the key players in the Europe Lab-on-a-Chip and Microarrays (Biochip) Market are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, ThermoFisher Scientific, F. Hoffmann-La Roche Ltd, BioMérieux and Illumina Inc.

Europe Lab-on-a-Chip and Microarrays (Biochip) Market Leaders

  1. ThermoFisher Scientific

  2. Agilent Technologies

  3. Bio-Rad Laboratories

  4. Abbott Laboratories

  5. Perkin Elmer Inc.

*Disclaimer: Major Players sorted in no particular order

Europe Biochip Market Concentration.png
Need More Details on Market Players and Competitors?
Download PDF

Europe Lab-on-a-Chip and Microarrays (Biochip) Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
    • 4.2.2 Increasing Demand for Point-of-Care-Testing
    • 4.2.3 Increasing Applications of Proteomics and Genomics in Cancer Research
  • 4.3 Market Restraints
    • 4.3.1 Design Constraints of Lab-on-chip Technology
    • 4.3.2 Availability of Alternative Technologies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Lab-on-a-Chip
    • 5.1.2 Microarray
  • 5.2 By Products
    • 5.2.1 Instruments
    • 5.2.2 Reagents & Consumables
    • 5.2.3 Software and Services
  • 5.3 By Application
    • 5.3.1 Clinical Diagnostics
    • 5.3.2 Drugs Discovery
    • 5.3.3 Genomics and Proteomics
    • 5.3.4 Others
  • 5.4 By End-User
    • 5.4.1 Biotechnology & Pharmaceutical Companies
    • 5.4.2 Hospitals & Diagnostics Centres
    • 5.4.3 Academic & Research Institute
  • 5.5 By Country
    • 5.5.1 Germany
    • 5.5.2 United Kingdom
    • 5.5.3 France
    • 5.5.4 Italy
    • 5.5.5 Spain
    • 5.5.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Agilent Technologies
    • 6.1.3 Bio-Rad Laboratories
    • 6.1.4 Perkin Elmer Inc.
    • 6.1.5 GE Healthcare
    • 6.1.6 ThermoFisher Scientific
    • 6.1.7 F. Hoffmann-La Roche Ltd
    • 6.1.8 BioMerieux
    • 6.1.9 Illumina Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject To Availablity
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Lab-on-a-Chip and Microarrays (Biochip) Industry Segmentation

As per the scope of the report, a biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time, to achieve higher throughput and speed. Europe Lab-on-a-Chip and Microarrays (Biochip) Market are segmented By Type, By Product, By Application, By End User and Country.

By Type Lab-on-a-Chip
Microarray
By Products Instruments
Reagents & Consumables
Software and Services
By Application Clinical Diagnostics
Drugs Discovery
Genomics and Proteomics
Others
By End-User Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostics Centres
Academic & Research Institute
By Country Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region Or Segment?
Customize Now

Europe Lab-on-a-Chip and Microarrays (Biochip) Market Research FAQs

The Europe Lab-on-a-chip and Microarrays (Biochip) Market is projected to register a CAGR of 11.13% during the forecast period (2024-2029)

ThermoFisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Abbott Laboratories and Perkin Elmer Inc. are the major companies operating in the Europe Lab-on-a-chip and Microarrays (Biochip) Market.

The report covers the Europe Lab-on-a-chip and Microarrays (Biochip) Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Lab-on-a-chip and Microarrays (Biochip) Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Inductive and LVDT Sensor Industry Report

Statistics for the 2024 Inductive and LVDT Sensor market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Inductive and LVDT Sensor analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Europe Lab-on-a-Chip and Microarrays Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)